Trial intelligence / Profile preview

PS76A2 (Lektinol) during adjuvant chemotherapy for breast cancer

2007-000841-36Phase 3Active

Sponsor
Rottapharm Madaus
Start
Aug 2009
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in breast cancer comparing Lektinol + adjuvant FEC chemotherapy with Placebo + adjuvant FEC chemotherapy (2 arms). Started Aug 2009; status: active.

02

Drugs

viscum album
03

Conditions

breast cancer

Beyond the preview

Go deeper on 2007-000841-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-000841-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call